Skip to main content
Top

Inflammation Research

Issue 10/2013

Content (7 Articles)

Original Research Paper

Comparison of inflammatory cytokine profiles in plasma of patients undergoing otorhinological surgery with propofol or isoflurane anesthesia

Marina Azer Mazoti, Mariana Gobbo Braz, Márjorie de Assis Golim, Leandro Gobbo Braz, Norimar Hernandes Dias, Daisy Maria Favero Salvadori, José Reinaldo Cerqueira Braz, Denise Fecchio

Original Research Paper

Procalcitonin induced cytotoxicity and apoptosis in mesangial cells: implications for septic renal injury

Magali Araujo, Sonia Q. Doi, Carlos E. Palant, Eric S. Nylen, Kenneth L. Becker

Original Research Paper

Inhibitory effects of epi-sesamin on endothelial protein C receptor shedding in vitro and in vivo

Sae-Kwang Ku, Wonhwa Lee, Hayoung Yoo, Chang-Kyun Han, Jong-Sup Bae

Original Research Paper

Critical role of interleukin-5 in the development of a mite antigen-induced chronic bronchial asthma model

Hiroki Shimizu, Yasushi Obase, Shigeki Katoh, Keiji Mouri, Yoshihiro Kobashi, Mikio Oka

Original Research Paper

Antiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort

Darcy S. Majka, Kiang Liu, Richard M. Pope, Elizabeth W. Karlson, Thanh-Huyen T. Vu, Marius Teodorescu, Rowland W. Chang

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine